Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05682742 · ClinicalTrials.gov registry record · NA

Clinical Investigation of the da Vinci Surgical System

A NA study of Prostate Cancer and Gynecologic Cancer, sponsored by Intuitive Surgical.

Active
Registry status
NA
Development phase
53
Enrollment target
4
Study locations

NCT05682742 is a NA study of Prostate Cancer and Gynecologic Cancer that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 53 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05682742, a NA study of Prostate Cancer and Gynecologic Cancer, is active but no longer recruiting, sponsored by Intuitive Surgical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
53 participants
Enrollment target
4
Study locations

Study Summary

This prospective, multicenter, single-arm study is being conducted to confirm safety, effectiveness, and usability of da Vinci Surgical System in performing robotic-assisted surgical procedures.

Interventions

  • DEVICE Robotic-assisted Surgery

Study Locations (4)

Florida

  • Orlando Health, Inc. - Orlando

Michigan

  • Sparrow Health System - Lansing

New Jersey

  • The Valley Hospital - Ridgewood

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2022-12-12
Est. Completion 2028-08-31
Phase NA

Sponsor

Intuitive Surgical

40 total trials

What the Registry Record Tells You About NCT05682742

The ClinicalTrials.gov registry entry for NCT05682742 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Intuitive Surgical, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic-assisted Surgery is the first listed.

NCT05682742 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Michigan, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05682742 about?

NCT05682742 is a clinical study titled "Clinical Investigation of the da Vinci Surgical System". This prospective, multicenter, single-arm study is being conducted to confirm safety, effectiveness, and usability of da Vinci Surgical System in performing robotic-assisted surgical procedures.

What is the current status of trial NCT05682742?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2022-12-12. Estimated completion is 2028-08-31.

What conditions does trial NCT05682742 study?

This clinical trial studies the following conditions: Prostate Cancer, Gynecologic Cancer, Pelvic Organ Prolapse, Obesity, Morbid, Ventral Hernia.

What interventions are being tested in trial NCT05682742?

The interventions under investigation include: Robotic-assisted Surgery (DEVICE).

Who is sponsoring clinical trial NCT05682742?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05682742 being conducted?

This trial has 4 study locations across Florida, Michigan, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.